Skip to main content
Log in

Budesonide/Formoterol Combination

A Viewpoint by Louis-Philippe Boulet

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Boulet LP. Long acting β2-agonists. In: Fitzgerald JM, Ernst P, Boulet LP, et al., editors. Evidence-based asthma management. New York: BC Dekker, 2001

    Google Scholar 

  2. Pauwels RA, Lofdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405–11

    Article  PubMed  CAS  Google Scholar 

  3. Kips JC, O’ Connor B, Inman M, et al. A long term study of the anti-inflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med 2000; 161: 996–1001

    PubMed  CAS  Google Scholar 

  4. Ankerst J, Persson G, Weibull E. A high dose of budesonide/formoterol in a single inhaler was well tolerated by asthmatic patients [abstract]. World Congress on Lung Health and 10th ERS Annual Congress. Eur Respir J 2000 Aug; 16 Suppl. 31: 33S

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boulet, LP. Budesonide/Formoterol Combination. Drugs 61, 79 (2001). https://doi.org/10.2165/00003495-200161010-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200161010-00008

Keywords

Navigation